Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T H Inge

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophoreT M Tuttle, T H Inge, C M McCrady, et al.
Annals of Surgical Oncology|January 1, 1994
Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.
Cancer Research|March 15, 1992
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1T H Inge, S K Hoover, B M Susskind, et al.
International Journal of Obesity (2005)|August 29, 2015
Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesityA S Kelly, J R Ryder, K L Marlatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytesT H Inge, K M McCoy, B M Susskind, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
A cytotoxic T-lymphocyte clone derived from mice with progressively growing tumorsS K Hoover, T H Inge, J L Frank, et al.
The Journal of Surgical Research|June 1, 1992
Bryostatin 1-activated T cells can traffic and mediate tumor regressionT M Tuttle, K P Bethke, T H Inge, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Bryostatin 1 activates T cells that have antitumor activityT M Tuttle, T H Inge, C P Wirt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamideT H Inge, S K Hoover, J L Frank, et al.
Cancer Research|February 1, 1992
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1T M Tuttle, T H Inge, K P Bethke, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|July 1, 1992
Activation of CD8+ murine T cells from tumor-draining lymph nodes by phorbol dibutyrate plus calcium ionophoreT M Tuttle, T H Inge, C M McCrady, et al.
Annals of Surgical Oncology|January 1, 1994
Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppressionT M Tuttle, M D Fleming, P S Hogg, et al.
Cancer Research|March 15, 1992
Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1T H Inge, S K Hoover, B M Susskind, et al.
International Journal of Obesity (2005)|August 29, 2015
Changes in inflammation, oxidative stress and adipokines following bariatric surgery among adolescents with severe obesityA S Kelly, J R Ryder, K L Marlatt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1992
Immunomodulatory effects of transforming growth factor-beta on T lymphocytes. Induction of CD8 expression in the CTLL-2 cell line and in normal thymocytesT H Inge, K M McCoy, B M Susskind, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1991
A cytotoxic T-lymphocyte clone derived from mice with progressively growing tumorsS K Hoover, T H Inge, J L Frank, et al.
The Journal of Surgical Research|June 1, 1992
Bryostatin 1-activated T cells can traffic and mediate tumor regressionT M Tuttle, K P Bethke, T H Inge, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy|August 1, 1992
Bryostatin 1 activates T cells that have antitumor activityT M Tuttle, T H Inge, C P Wirt, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1992
Enhancement of cytotoxic T lymphocyte growth from spleens of P815-tumor-bearing host mice with mafosfamideT H Inge, S K Hoover, J L Frank, et al.
Cancer Research|February 1, 1992
Activation and growth of murine tumor-specific T-cells which have in vivo activity with bryostatin 1T M Tuttle, T H Inge, K P Bethke, et al.
Pageof 3